BlackJ.W., and StephensonJ.S.Pharmacology of a new beta-receptor blocking compound (Nethalide); Lancet1962; 2: 311.
2.
FrishmanW., and SilvermanR.Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 2. Physiologic and metabolic effects. Amer Heart J1979; 97: 797.
3.
FrishmanW., SilvermanR., StromJ., ElkayamU., and SonnenblickE.Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 4. Adverse effects. Choosing a beta-adrenoreceptor blocker. Amer Heart J1979; 98: 256.
AhlquistR.P.A study of adrenotropic receptors. Amer J Physiol1948; 153: 586.
6.
NickersonM., and GoodmanL.S.Pharmacologic properties of a new adrenergic blocking agent: N2O — dibenzyl-β-chloro-ethylamine (Dibenamine). J Pharmacol1947; 89: 167.
7.
PowellC.J., and SlaterI.H.Blocking of inhibitory adrenergic receptors by a dichloro analog of isoproterenol. J Pharmacol Exp Ther1958; 122: 480.
8.
FitzgeraldJ.O.Perspectives in beta adrenergic blockade. Clin Pharmacol1969; 10: 292.
9.
LandsA.M., ArnoldD.A., McAuliffJ.P., LudvenaF.P., and BrownT.L.Differentiation of receptor systems activated by sympathomimetic amines. Nature1967; 214: 597.
10.
Vaughan WilliamsE.M.Biophysical background to beta blockade. In, New perspectives in beta blockade II1973; p 11, Ciba, Horsham, England.
11.
AhlquistR.P.Present state of alpha and beta adrenergic drugs II. The adrenergic blocking agents. Amer Heart J1976; 92: 804.
12.
FrishmanW.Clinical pharmacology of the new beta-adrenergic blocking drugs. Part I. Pharmacodynamics and pharmacokinetic properties. Amer Heart J1979; 97: 663.
13.
Morales-AguileraA., and Vaughan WilliansE.M.The effects of cardiac muscle of β receptor antagonists in relation to their activity as local anaesthetics. Br J. Pharmacol1965; 24: 332.
14.
Prys-RobertsC.Hemodynamic effects of anaesthesia and surgery in renal hypertensive patients receiving large doses of β-receptor antagonists. Anesthesiology1979; 51: S122.
15.
CannonW.B.Bodily changes in pain, hunger, fear and rage.Appleton & Co1929; New York and London.
16.
PorteD Jnr. Beta adrenergic stimulation of insulin release in man. Diabetes1967; 16: 150.
17.
Hims-HagenJ.H.Sympathetic regulation of metabolism. Pharmacol Rev1967; 19: 367.
18.
BiscoeT.J., and MillarR.A.The effect of cyclopropane, halothane and ether on sympathetic ganglionic transmission. Br J Anaesth1966; 38: 3.
19.
PriceH.L., WardenJ.C., CoopermanL.H., and MillarR.A.Central sympathetic excitation caused by cyclopropane. Anesthesiology1969; 30: 426.
20.
SkovstedP., and PriceH.L.Central sympathetic excitation caused by fluroxene. Anesthesiology1970; 32: 210.
21.
SkovstedP., and PriceH.L.Central sympathetic excitation caused by diethyl ether. Anesthesiology1970; 32: 202.
22.
GarfieldJ.M., AlperM.H., GillisR.A., and FlackeW.A pharmacological analysis of ganglionic actions of some general anaesthetics. Anesthesiology1968; 29: 79.
23.
BlackG.W., GlasgowJ.T.F., and SmithB.T.Management of phaeochromocytoma in a child. Br J Anaesth1969; 41: 184.
24.
PriceH.L., CookW.A., DeutschS., LindeH.W., MishaloveR.D., and MorseH.T.Hemodynamic and central nervous actions of cyclopropane in the dog. Anesthesiology1963; 24: 1.
25.
SmithN.T., EgerE.I. I.I., StoeltingR.K., WhayneT.F., CullenD., and KadisL.B.The cardiovascular and sympathomimetic responses to the addition of nitrous oxide to halothane in man. Anesthesiology1970; 32: 410.
26.
UnniV.K.N., McArdleL., and BlackG.W.Sympathoadrenal, respiratory and metabolic changes during trichlorethylene anaesthesia. Br J Anaesth1970; 42: 429.
27.
RobertsJ.G., FoexP., ClarkeT.N.S., BennettM.J., and SanerC.A.Haemodynamic interactions of high dose propranolol pretreatment and anaesthesia in the dog. III. The effects of haemorrhage during halothane and trichlorethylene anaesthesia. Br J Anaesth1976; 48: 411.
28.
DobkinA.B., HeinrichR.G., IsraelJ.S., LevyA.A.Jr., and OunkasemJ.Clinical and laboratory evaluation of a new inhalation agent: Compound 347 (CHF2-O-CF2-CHFCl). Anesthesiology1968; 29: 275.
29.
LiT.H., ShaulM.S., and EtstenB.E.Decreased adrenal venous catecholamine concentrations during methoxyflurane anesthesia. Anesthesiology1968; 29: 1145.
30.
StevensW.C., CromwellT.H., HalseyM.J., EgerE.I. I.I., ShakespearT.J., and BahlmanS.H.The cardiovascular effects of a new inhalational anesthetic, forane, in human volunteers at constant arterial carbon dioxide tension. Anesthesiology1971; 35: 8.
31.
HoranB.F., Prys-RobertsC., RobertsJ.G., BennettM.J., and FoexP.Haemodynamic reponses to isoflurane anaesthesia and hypovolaemia in the dog, and their modification by propranolol. Br J Anaesth1977; 49: 1179.
32.
BristowJ.D., Prys-RobertsC., and FisherA.Quantification of baroreceptor reflexes during anaesthesia in man. Br J Anaesth1969; 41: 556.
33.
CraythorneN.W.B., and HuffingtonP.E.Effects of propranolol on the cardiovascular response to cyclopropane and halothane. Anesthesiology1966; 27: 580.
34.
JorfeldtL., LofstromB., MollerJ., and RosenA.Cardiovascular pharmacodynamics of propranolol during ether anaesthesia in man. Acta Anaesthesiol Scand1967; 11: 159.
35.
NormanJ., and AtkinsonS.A.Effect on cardiac sympathetic blockade on the relationship between cardiac output and carbon dioxide tension in the anaesthetised dog. Br J Anaesth1970; 42: 592.
36.
ClarkeT.N.S., Prys-RobertsC., BiroG., FoexP., RobertsJ.G., and BennettM.J.Compensatory mechanisms in haemodilutional anaemia. Br J Anaesth1974; 46: 798.
37.
StrongA.J., MacNicolM.F., DavieI.T., and ScottD.B.The effects of beta-blockade on left ventricular performance in experimental halothane anaesthesia. Br J Anaesth1972; 44: 1006.
38.
GuedelA.E.Current researches in anaesthesia1920; May, 1: 1920.
MillarR.A., WardenJ.C., CoopermanL.H., and PriceH.L.Further studies of sympathetic actions of anaesthetics in intact and spinal animals. Br J Anaesth1970; 42: 366.
41.
RyderW.Cardiac rhythm during dental anaesthesia. Proc Roy Soc Med1971; 64: 1, 82.
42.
AlexanderJ.P.Dysrhythmia and oral surgery. Br J Anaesth1971; 43: 773.
43.
RollasonW.N., and HallD.J.Dysrhythmias during inhalational anaesthesia for oral surgery. Incidence and prevention and treatment with practolol. Anaesthesia1973; 28: 139.
44.
JenkinsA.N.Adrenergic beta-blockade with ICI 50172 (Practolol, “Eraldin”) during bronchoscopy. Br J Anaesth1970; 42: 59.
45.
Prys-RobertsC., FoexP., BiroG.P., and RobertsJ.G.Studies of anaesthesia in relation to hypertension. V: Adrenergic beta receptor blockade. Br J Anaesth1973; 45: 671.
46.
BraunwaldE.Control of myocardial oxygen consumption. Physiologic and clinical considerations. Amer J Cardiol1971; 27: 416.
47.
SomervilleW., TaggartP., and CarruthersM.Cardiovascular responses to public speaking and their modification by oxprenolol. In, New Perspectives in Beta Blockade1973; p. 275, Ciba, Horsham, England.
48.
BoudoulasH., LewisR.P., KatesR.E., and DalamangasG.Hypersensitivity to adrenergic stimulation after propranolol withdrawal in normal subjects. Annal Int Med1977; 87: 433.
49.
MillerR.R., OlsenH.G., AmsterdamE.A., and MasonD.T.Propranolol withdrawal rebound phenomenon: exacerbation of coronary events after abrupt cessation of anti-anginal therapy. N Eng J Med1975; 293: 416.
50.
KaplanJ.A., DunbarR.W., BlanJ.W.Jr., SumpterR., and JonesE.F.Propranolol and cardiac surgery: A problem for the anesthesiologist?Anesth Analg1975; 54: 571.
51.
ViljoenJ.F., EstafanousF., and KellnerG.A.Propranolol and cardiac surgery. J Thor Cardiovasc Surg1972; 64: 826.
52.
SanerC.A., FoexP., RobertsJ.G., and BennettM.J.Methoxyflurane and practolol: A dangerous combination?Br J Anaesth1975; 47: 1025.
53.
KoprivaC.J., BrownA.C.D., and PappasG.Haemodynamics during general anaesthesia in patients receiving propranolol. Anesthesiology1978; 48: 28.
54.
Prys-RobertsC., RobertsJ.G., FoexP., ClarkeT.N.S., BennettM.J., and RyderW.A.Interactions of anaesthesia, beta-receptor blockade and blood loss in dogs with induced myocardial infarction. Anesthesiology1976; 45: 326.
55.
NaylerW.C., and ChangA.Cellular pharmacology of beta blocking drugs. In, New Perspectives in Beta Blockade1973; p. 41, Ciba, Horsham, England.
56.
MeierM.Comparative pharmacology of beta-adrenergic blocking drugs. In, New Perspectives in Beta Blockade1973; p. 89, Ciba, Horsham, England.
57.
ScalesB., and McIntoshD.A.D.Effects of propranolol and its optical isomers on the radio calcium uptake and the adenosine triphosphatases of skeletal and cardiac sarcoplasmic reticulum fractions (SRF). J Pharmacol Exp Ther1968; 160: 261.
58.
WeissG.B.On the site of action of lanthanum in frog sartorius muscle. J Pharmacol Exp Ther1970; 174: 517.
59.
ChaseM.H., and ClementeC.D.Central neural components of the autonomic nervous system. Anesthesiology1968; 29: 625.
60.
GanderM., VeragutV., KohlerR., and LuthyE.Cardiac haemodynamics under β-receptor blockade in dogs. Cardiology (Basel)1966; 49: Suppl 11, 17.
61.
NakanoJ., and TakashiK.Effect of beta adrenergic blockade on the cardiovascular dynamics. Amer J Physiol1966; 210(4): 833.
62.
HarryJ.D., KappagodaC.T., LindenR.J., and SnowH.M.Action of propranolol on the dog heart. Cardiovasc Res1973; 7: 729.
63.
RouseW.The effects of propranolol on the response to ether anaesthesia in anaesthetised dogs. Anaesthesia1967; 24: 157.
64.
MerinR.G., and TonnesenA.L.Effect of beta adrenergic blockade on myocardial haemodynamics and metabolism during light halothane anaesthesia. Canad Anaesth Soc J1969; 16: 336.
65.
WeisK.H., and BrackebuschH.D.On the cardiovascular effect of propranolol during halothane anaesthesia in normovolaemic and hypovolaemic dogs. Br J Anaesth1970; 42: 272.
66.
MerinR.G.Myocardial metabolism and dynamics after practolol during light halothane anaesthesia. Br J Anaesth1972; 44: 437.
67.
StrongA.J., MacNicolM.F., DavieI.T., and ScottD.B.Haemodynamic effects of oxprenolol and practolol in dogs under halothane anaesthesia. Br J Anaesth1971; 43: 25.
68.
RobertsJ.G., and FoexP.Haemodynamic effects of oxprenolol during anaesthesia: Dose response studies. Clin Exp Physiol Pharmacol1978; 5: 268.
69.
RobertsJ.G., FoexP., ClarkeT.N.S., and BennettM.J.Haemodynamic interactions of high-dose propranolol pretreatment and anaesthesia in the dog. I: Halothane dose-response studies. Br J Anaesth1976; 48: 315.
70.
RobertsJ.G., FoexP., ClarkeT.N.S., Prys-RobertsC., and BennettM.J.Haemodynamic interactions of high-dose propranolol pretreatment and anaesthesia in the dog. II: The effects of acute arterial hypoxaemia at increasing depths of halothane anaesthesia. Br J Anaesth1976; 48: 403.
71.
RobertsJ.G., and FoexP.Haemodynamic effect of oxprenolol during anaesthesia: effects of haemorrhage and hypoxia during long term oral oxprenolol therapy. In preparation.
72.
FoexP., SanerC.A., FordhamR.M.M., RobertsJ.G., and BennettM.J.CO2 ‘washout’: A factor contributing to increased myocardial performance in the face of hypoxia. Bull Eur Physiopath Resp1976; 12: 231.
73.
HoranB.F., Prys-RobertsC., HamiltonW.K., and RobertsJ.G.Haemodynamic responses to enflurane anaesthesia and hypovolaemia in the dog, and their modification by propranolol. Br J Anaesth1977; 49: 1189.
74.
PhilbinD.M., and LowensteinE.Haemodynamic consequences of the combination of isoflurane anaesthesia (I MAC) and beta-adrenergic blockade in the dog. Anesthesiology1975; 42: 567.
75.
PhilbinD.M., and LowensteinE.Lack of beta-adrenergic activity of isoflurane in the dog: a comparison of circulatory effects of halothane and isoflurane after propranolol administration. Br J Anaesth1976; 48: 1165.
76.
VogelJ.H.K., and BlountS.G.Jr.. Modification of cardiovascular responses by propranolol. Br Heart J1967; 29: 310.
77.
UlrychM., FrolichE.D., DustanH.P., and PageI.H.Immediate haemodynamic effects of beta-adrenergic blockade with propranolol in normotensive and hypertensive man. Circulation1968; 37: 411.
78.
SowtonE., BalcanR., CrossD., and FrickH.Haemodynamic effects of ICI 50172 in patients with ischaemic heart disease. Br Med J1968; 1: 215.
79.
GentG., DavisT.C., and McDonaldA.Practolol in treatment of supraventricular cardiac dysrhythmias. Br Med J1970; 1: 533.
80.
VickersR.D.Adrenergic drugs and their antagonists in anaesthesia. Br J Anaesth1966; 38: 728.
81.
JohnstoneM.Beta adrenergic blockade with pronethalol during anaesthesia. Br J Anaesth1964; 36: 224.
82.
JohnstoneM.Propranolol (Inderal) during halothane anaesthesia. Br J Anaesth1966; 38: 516.
83.
JohnstoneM.Reflections on beta-adrenergic blockade in anaesthetics. Br J Anaesth1970; 42: 262.
84.
HellewellJ., and PottsM.W.Propranolol and ventricular arrhythmias with halothane. Anaesthesia1965; 20: 269.
85.
MathiasJ.A., and PayneJ.P.Practolol in the management of cardiac dysrhythmias in patients anaesthetised with halothane. Br J Pharmacol1970; 40: 572.
86.
JohnstoneM.Cardiac dysrhythmias during anaesthesia with special reference to practolol (Eraldin); Acta. Cardiologica (Brux) Suppl1972; 25: 293.
87.
WarnerW.A.Beta adrenergic blocking drugs and anaesthesia: A review. Canad Anaesth Soc J1968; 15: 42.
88.
WhittyA.J., and ShepardR.S.Role of the vagus in control of cardiac output in the anaesthetised dog. Amer J Physiol1967; 213: 1520.
89.
WhitsittL.S., and LucchesiB.R.Effects of propranolol and its stereo-isomers upon coronary vascular resistance. Circ Res1967; 21: 305.
90.
NaylerW.G., McInnesI., SwannJ.B., CarsonV., and LoseT.E.Effect of propranolol, a beta adrenergic antagonist, on blood flow in the coronary and other vascular fields. Amer Heart J1967; 73: 207.
91.
PittB., ElliottE.C., and GreggD.E.Adrenergic receptor activity in the coronary arteries of the unanaesthetised dog. Circ Res1967; 21: 75.
92.
PittB., GreeneH.L., SugishitaY., and RossR.S.Effect of beta-adrenergic receptor blockade on coronary haemodynamics in the resting, unanaesthetised dog. Cardiovasc Res1970; 4: 89.
93.
BussmanW.D., RanhM., and KrayenbuehlH.P.Coronary and haemodynamic effects of myocardioselective beta-receptor blockade by ICI 150172 in the closed chest dog. Amer Heart J1970; 79: 347.
94.
McKennaD.H., CorlissR.J., SialerS., ZarstorffW.C., CrumptonC.W., and RoweG.G.Effect of propranolol on systemic and coronary haemodynamics at rest and during simulated exercise. Circ Res1966; 19: 520.
95.
BurtG., and FoexP.Effects of metoprolol on systemic haemodynamics, myocardial performance and the coronary circulation during halothane anaesthesia. Br J Anaesth1979; 51: 829.
96.
MerinR.G.Anaesthetic management problems posed by therapeutic advances. III. Beta-adrenergic blocking drugs. Anesth Analg1972; 51: 617.
97.
MorrowD.H.The experts opine. Survey of Anesthesiology1972; 16: 487.
98.
FredericksonE.L.The experts opine. Survey of Anesthesiology1972; 16: 487.
99.
ClarkeR.S.J.The place of some newer non-anaesthetic drugs in anaesthetic practice. Int Anesthesiol Clin1973; 11: 15.
100.
DundeeJ.W., and McCaugheyW.Interaction of drugs associated with anaesthesia. Int Anesthesiol Clin1973; 11: 41.
101.
KaplanJ.A., and DunbarR.W.Propranolol and surgical anaesthesia. Anesth Analg1975; 55: 1–5.
102.
AyscueQ.A.The experts opine. Survey of Anesthesiology1972; 16: 485.
103.
ShimosatoS.The experts opine. Survey of Anesthesiology1972; 16: 489.
104.
FabianL.W.The experts opine. Survey of Anesthesiology1972; 16: 484.
105.
ViljoenJ.F., and GindiM.Y.Anaesthesia for coronary artery surgery. Surg Clin North Am1972; 51: 1081.
106.
FaulknerS.L., HopkinsJ.T., BoerthR.C., YoungJ.L., JellertA.S., NiesA.S., BenderH.W., and ShandD.G.Time required for complete recovery from chronic propranolol therapy. N Eng J Med1973; 289: 607.
107.
MannersJ.M., and WaltersF.J.M.Beta-adrenoreceptor blockade and anaesthesia for coronary artery surgery. Anaesthesia1979; 34: 3.
108.
KatzR.L., and BiggerJ.T.Cardiac arrhythmias during anaesthesia and operation. Anesthesiology1970; 33: 193.
109.
ScottD.B., BuckleyF.P., LittlewoodD.G., MacraeW.R., ArthurG.R., and DrummondG.B.Circulatory effects of labetolol during halothane anaesthesia. Anaesthesia1978; 33: 145.